Precision Medicine, Big Data, Innovative Financing and Emerging Markets Are
Focus of MIT Sloan BioInnovations Conference
Margaret Hamburg, Food and Drug Administration Commissioner, and George
Church, Director of Personal Genome Project, to serve as keynote speakers
MIT Sloan BioInnovations Conference 2014
CAMBRIDGE, Mass. -- February 12, 2014
Innovations in genomics technology have made the genetic information of
individuals very accessible. This information, in turn, is being used in a
growing array of diagnostic and treatment-tuning capacities.
On Friday, February 28, the MIT Sloan BioInnovations Conference will bring
together industry, academic and policy leaders to address trends and new
approaches to precision medicine along with the impact of big data on
healthcare, innovative financing, and new opportunities in emerging markets.
The conference will be held at the Boston Marriott Cambridge hotel in Kendall
Slated keynote speakers are:
*Dr. Margaret Hamburg, Commissioner, Food and Drug Administration
*Dr. George Church, Wyss Institute of Synthetic Biology & Director of
Personal Genome Project
*Alex Azar, President, Lilly USA, LLC at Eli Lilly and Company
*Kieran Murphy, President and CEO, GE Healthcare Life Sciences
Four panels will focus on:
Innovation Trends in Upstream R&D and Phase I Pipeline Development
A look at pre-competitive consortia of pharma companies, big-data-related
methods of generating or capturing chemical and biological diversity, and
novel therapeutic modalities such as RNA interference, gene therapy, cell
therapy and viral therapy.
Big Data in Healthcare: Where Does That Lead Us?
A look at the wealth of opportunities and challenges brought on by big data,
and how players in the healthcare industry are seeking to capitalize on this
information to help drive more innovation to improve healthcare outcomes.
Seizing Uncaptured Opportunities in Emerging Markets
Common challenges around regulation, distribution, access, and affordability
across diverse emerging markets, as well as innovative approaches in
addressing these challenges will be explored.
Transforming Healthcare Entrepreneurship with Innovative Financing
The transformation of the US healthcare system has created a paradigm shift in
how start-ups are seeded, grown, and assessed. This panel will encourage
discussion on innovative approaches to grow and finance healthcare ventures.
For more information and to register, please visit:
About the MIT Sloan BioInnovations Conference
The MIT Sloan BioInnovations conference has established itself as an important
forum for leaders in industry, academia, and policy to discuss current issues
and future innovations in the dynamic area of healthcare, from healthcare in
emerging markets to new drug technologies. Participants will hear from
industry leaders in keynote addresses and panel discussions, will view new
technological and business innovations from the many biomedical institutes and
startups around Boston through poster presentations, and will have the
opportunity to network with professionals and students from a variety of
MIT Sloan School of Management
Director of Media Relations
Associate Director of Media Relations
Press spacebar to pause and continue. Press esc to stop.